Search for a report

Reports

  • You are here:
  • Home
  • Downloads
  • GLOBAL DRUG DELIVERY MARKET FORECAST 2022-2030

GLOBAL DRUG DELIVERY MARKET FORECAST 2022-2030

The global drug delivery market is predicted to register a CAGR of 6.84% between 2022 and 2030 and is expected to generate revenue of $2988.1 billion by 2030.

Drug delivery is the process of administering a pharmaceutical compound in order to provide therapy for various diseases. Recently, manufacturers have been establishing various efforts in the area of drug delivery, including the development of targeted drug delivery devices wherein the drug is only active in the body’s target area.

GLOBAL DRUG DELIVERY MARKET FORECAST 2022-2030

Global Drug Delivery Market by Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Pulmonary Drug Delivery, Topical Drug Delivery, Nasal Drug Delivery, Ocular Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery) Market by End-user (Hospitals, Ambulatory Surgical Centers, Home Care Settings, Other End-users) by Geography

Request free sample

The global drug delivery market is predicted to register a CAGR of 6.84% between 2022 and 2030 and is expected to generate revenue of $2988.1 billion by 2030.

Drug delivery is the process of administering a pharmaceutical compound in order to provide therapy for various diseases. Recently, manufacturers have been establishing various efforts in the area of drug delivery, including the development of targeted drug delivery devices wherein the drug is only active in the body’s target area.

Drug Delivery Market

To know more about this report, request a free sample copy

Key factors propelling the global drug delivery market growth:

  • Technological advancements in drug delivery techniques
  • Increasing usage of biological drugs
    • The rising demand for biological drugs provides public as well as private companies with opportunities for increasing their healthcare expenditure.
    • It also facilitates a rise in research and development investment on advanced and novel approaches to deliver biologics drugs with cost-effective drug delivery systems.
  • Growing demand for effective drug delivery mechanisms
  • Rising incidence of chronic diseases and prevailing aging population

Major growth restraining factors:

  • Increasing drug recalls and drug failures
    • Over recent years, the number of recalls linked to drug delivery devices has significantly increased due to safety concerns, thus anticipated to hamper the market’s growth.
  • Government regulations delaying the process
  • Side effects and risks associated with the drugs

The report scope of the global drug delivery market includes segmentation analysis based on route of administration and end-user. One of these segments is further classified to provide a detailed analysis of the studied market.

Market by Route of Administration:

  • Oral Drug Delivery
    • Oral drug delivery (ODD) is the highest revenue-generating route of administration.
    • Oral drug delivery is the most preferred and suitable route of drug administration since it offers high patient compliance, non-invasiveness, least sterility constraints, and cost-effectiveness.
  • Injectable Drug Delivery
    • Injectable drug delivery is the fastest-growing segment within the route of administration category.
    • One of the most active routes of administration is injectable drug delivery, on account of its effectiveness and speed of distribution to the target site.
  • Pulmonary Drug Delivery
  • Topical Drug Delivery
  • Nasal Drug Delivery
  • Ocular Drug Delivery
  • Transmucosal Drug Delivery
  • Implantable Drug Delivery

Geographically, the global drug delivery market has been segmented based on four major regions, which includes:

  • North America: The United States and Canada
    • North America dominated the global drug delivery market in 2021.
    • The United States is set to capture the largest revenue share across the North America drug delivery market.
    • The regional market is primarily driven by the increasing prevalence of chronic diseases like asthma, diabetes, the surging use of drug delivery devices for disease management, and the growing number of product launches by key players.
  • Europe: The United Kingdom, Germany, Italy, France, Spain, Poland, Belgium, Russia, and Rest of Europe
  • Asia-Pacific: Japan, India, China, South Korea, Australia & New Zealand, Indonesia, Thailand, Vietnam, and the Rest of Asia Pacific
    • Asia-Pacific is expected to be the fastest-growing region for drug delivery during the forecast period.
    • The regional market’s growth is accredited to the increase in healthcare awareness, growth in disposable incomes, large patient pools, rising healthcare expenditure, and surge in government spending.
  • Rest of World: Latin America, the Middle East & Africa

Major market players operating in the global drug delivery market:

  • Bayer AG
  • Becton, Dickinson and Company (BD)
  • Baxter International Inc
  • Johnson & Johnson
  • Novartis

Key strategies adopted by some of these companies:

In January 2021, Novartis and GSK announced the launch of a collaboration to support scientific research investigating the connection between genomic diversity across different provinces in Africa and its possible impact on response to drug therapeutics.

Key findings of the global drug delivery market:

  • High growth prospects in emerging markets are set to provide the global drug delivery market with lucrative growth opportunities.
  • The introduction of novel drug delivery systems is a key factor fueling the global drug delivery market growth.

Frequently Asked Questions (FAQs):

  • What is the role of biologic drugs on the global drug delivery market?

A: Biologic drugs are the driving force of the pharmaceutical industry, with drug delivery devices representing chief avenues, mainly in terms of the discovery of novel biologic drugs. Hence, the development in the biologics market is anticipated to impact the global drug delivery devices market in notable ways.

  • How does the prevalence of chronic diseases boost the global drug delivery market?

A: Due to the rising prevalence of chronic diseases, drug delivery devices have continued to increase across the globe. Hence, the increasing number of patients suffering from one or more chronic diseases is expected to boost the growth of the global drug delivery market over the upcoming years.

  • Which is the largest revenue-generating and fastest-growing end-user in the global drug delivery market?

A: Hospitals are the largest revenue-generating and fastest-growing end-user in the global drug delivery market.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • TECHNOLOGICAL ADVANCEMENTS IN DRUG DELIVERY TECHNIQUES
        • INCREASING USAGE OF BIOLOGICAL DRUGS
        • GROWING DEMAND FOR EFFECTIVE DRUG DELIVERY MECHANISMS
        • RISING INCIDENCE OF CHRONIC DISEASES AND PREVAILING AGING POPULATION
      • KEY RESTRAINTS
        • INCREASING DRUG RECALLS AND DRUG FAILURES
        • GOVERNMENT REGULATIONS DELAYING PROCESSES
        • SIDE EFFECTS AND RISKS ASSOCIATED WITH THE DRUGS
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON DRUG DELIVERY MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • KEY BUYING CRITERIA
      • REGULATORY FRAMEWORK
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
    2. MARKET BY ROUTE OF ADMINISTRATION
      • ORAL DRUG DELIVERY
        • SOLID ORAL DRUGS
          • TABLETS
          • CAPSULES
          • POWDERS
          • PILLS
        • LIQUID ORAL DRUGS
          • SOLUTIONS
          • SYRUPS
        • SEMI-SOLID ORAL DRUGS
          • ORAL EMULSIONS
          • GELS
          • ELIXIRS
      • INJECTABLE DRUG DELIVERY
        • FORMULATIONS
          • CONVENTIONAL DRUG DELIVERY INJECTIONS
          • LONG ACTING INJECTABLE
          • NOVEL DRUG DELIVERY FORMULATIONS
        • DEVICES
          • CONVENTIONAL INJECTION DEVICES
            • CONVENTIONAL INJECTION DEVICES BY MATERIAL
              • PLASTIC
              • GLASS
            • CONVENTIONAL INJECTION DEVICES BY PRODUCT
              • FILLABLE SYRINGES
              • PREFILLED SYRINGES
            • CONVENTIONAL INJECTION DEVICES BY USABILITY
              • DISPOSABLE SYRINGES
              • REUSABLE SYRINGES
            • SELF-INJECTION DEVICES
              • NEEDLE-FREE INJECTORS
              • PEN INJECTORS
              • AUTO-INJECTOR
              • WEARABLE INJECTORS
            • OTHER INJECTOR DEVICES
      • PULMONARY DRUG DELIVERY
        • DEVICES
          • METERED DOSE INHALERS (MDIS)
          • NEBULIZERS
            • JET NEBULIZERS
            • ULTRASONIC NEBULIZERS DELIVERY
            • SOFT MIST NEBULIZERS
          • DRY POWDER SYSTEM
        • FORMULATIONS
      • TOPICAL DRUG DELIVERY
        • FORMULATIONS
          • SEMI-SOLID TOPICAL DRUG DELIVERY
            • CREAMS
            • OINTMENTS
            • LOTIONS
            • GELS
            • PASTES
          • LIQUID TOPICAL DRUG DELIVERY
            • SOLUTIONS
            • SUSPENSIONS
          • SOLID TOPICAL DRUG DELIVERY
            • POWDERS
            • SUPPOSITORIES
          • DEVICES
            • TRANSDERMAL PATCHES
            • TRANSDERMAL GELS
      • NASAL DRUG DELIVERY
        • NASAL SPRAYS
        • NASAL DROPS
        • NASAL GELS
        • NASAL POWDERS
      • OCULAR DRUG DELIVERY
        • FORMULATIONS
          • LIQUID FORMULATION
            • EYE DROPS
            • LIQUID SPRAYS
          • SEMI-SOLID FORMULATION
            • EYE OINTMENTS
            • GELS
          • OCULAR DEVICES
            • DRUG-COATED CONTACT LENSES
            • OCULAR INSERT
      • TRANSMUCOSAL DRUG DELIVERY
        • ORAL TRANSMUCOSAL DRUG DELIVERY
          • BUCCAL DRUG DELIVERY
          • SUBLINGUAL DRUG DELIVERY
        • OTHER TRANSMUCOSAL DRUG DELIVERY
          • RECTAL TRANSMUCOSAL DRUG DELIVERY
          • VAGINAL TRANSMUCOSAL DRUG DELIVERY
      • IMPLANTABLE DRUG DELIVERY
        • ACTIVE IMPLANTABLE DRUG DELIVERY
        • PASSIVE IMPLANTABLE DRUG DELIVERY
    1. MARKET BY END-USER
      • HOSPITALS
      • AMBULATORY SURGICAL CENTERS
      • HOME CARE SETTINGS
      • OTHER END-USERS
    2. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • GERMANY
          • FRANCE
          • UNITED KINGDOM
          • ITALY
          • SPAIN
          • RUSSIA
          • POLAND
          • BELGIUM
          • REST OF EUROPE
      • ASIA-PACIFIC
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • CHINA
          • JAPAN
          • INDIA
          • AUSTRALIA & NEW ZEALAND
          • SOUTH KOREA
          • INDONESIA
          • THAILAND
          • VIETNAM
          • REST OF ASIA-PACIFIC
      • REST OF WORLD
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • REGIONAL ANALYSIS
          • LATIN AMERICA
          • MIDDLE EAST & AFRICA
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
        • BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
      • COMPANY PROFILES
        • ALKERMES PLC
        • ANTARES PHARMA INC
        • BAUSCH HEALTH COMPANIES INC (FORMERLY VALEANT PHARMACEUTICALS)
        • BAXTER INTERNATIONAL INC
        • BAYER AG
        • BECTON, DICKINSON AND COMPANY (BD)
        • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
        • BOSTON SCIENTIFIC CORPORATION
        • GENEREX BIOTECHNOLOGY CORPORATION
        • GLAXOSMITHKLINE PLC
        • JOHNSON & JOHNSON
        • KINDEVA DRUG DELIVERY (FORMERLY 3M DRUG DELIVERY SYSTEMS)
        • NOVARTIS AG
        • NOVO NORDISK A/S
        • TERUMO MEDICAL CORPORATION (MICROVENTION INC)

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – DRUG DELIVERY

    TABLE 2: GLOBAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 3: GLOBAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 4: GLOBAL ORAL DRUG DELIVERY MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 5: GLOBAL ORAL DRUG DELIVERY MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 6: GLOBAL SOLID ORAL DRUGS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 7: GLOBAL SOLID ORAL DRUGS MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 8: GLOBAL LIQUID ORAL DRUGS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 9: GLOBAL LIQUID ORAL DRUGS MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 10: GLOBAL SEMI-SOLID ORAL DRUGS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 11: GLOBAL SEMI-SOLID ORAL DRUGS MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 12: GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 13: GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 14: GLOBAL FORMULATIONS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 15: GLOBAL FORMULATIONS MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 16: GLOBAL DEVICES MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 17: GLOBAL DEVICES MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 18: GLOBAL CONVENTIONAL INJECTION DEVICES MARKET, BY MATERIAL, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 19: GLOBAL CONVENTIONAL INJECTION DEVICES MARKET, BY MATERIAL, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 20: GLOBAL CONVENTIONAL INJECTION DEVICES MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 21: GLOBAL CONVENTIONAL INJECTION DEVICES MARKET, BY PRODUCT, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 22: GLOBAL CONVENTIONAL INJECTION DEVICES MARKET, BY USABILITY, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 23: GLOBAL CONVENTIONAL INJECTION DEVICES MARKET, BY USABILITY, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 24: GLOBAL SELF-INJECTION DEVICES MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 25: GLOBAL SELF-INJECTION DEVICES MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 26: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 27: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 28: GLOBAL DEVICES MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 29: GLOBAL DEVICES MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 30: GLOBAL NEBULIZERS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 31: GLOBAL NEBULIZERS MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 32: GLOBAL TOPICAL DRUG DELIVERY MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 33: GLOBAL TOPICAL DRUG DELIVERY MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 34: GLOBAL FORMULATIONS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 35: GLOBAL FORMULATIONS MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 36: GLOBAL SEMI-SOLID TOPICAL DRUG DELIVERY MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 37: GLOBAL SEMI-SOLID TOPICAL DRUG DELIVERY MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 38: GLOBAL LIQUID TOPICAL DRUG DELIVERY MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 39: GLOBAL LIQUID TOPICAL DRUG DELIVERY MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 40: GLOBAL SOLID TOPICAL DRUG DELIVERY MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 41: GLOBAL SOLID TOPICAL DRUG DELIVERY MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 42: GLOBAL DEVICES MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 43: GLOBAL DEVICES MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 44: GLOBAL NASAL DRUG DELIVERY MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 45: GLOBAL NASAL DRUG DELIVERY MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 46: GLOBAL OCULAR DRUG DELIVERY MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 47: GLOBAL OCULAR DRUG DELIVERY MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 48: GLOBAL FORMULATIONS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 49: GLOBAL FORMULATIONS MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 50: GLOBAL LIQUID FORMULATION MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 51: GLOBAL LIQUID FORMULATION MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 52: GLOBAL SEMI-SOLID FORMULATION MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 53: GLOBAL SEMI-SOLID FORMULATION MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 54: GLOBAL OCULAR DEVICES MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 55: GLOBAL OCULAR DEVICES MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 56: GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 57: GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 58: GLOBAL ORAL TRANSMUCOSAL DRUG DELIVERY MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 59: GLOBAL ORAL TRANSMUCOSAL DRUG DELIVERY MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 60: GLOBAL OTHER TRANSMUCOSAL DRUG DELIVERY MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 61: GLOBAL OTHER TRANSMUCOSAL DRUG DELIVERY MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 62: GLOBAL IMPLANTABLE DRUG DELIVERY MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 63: GLOBAL IMPLANTABLE DRUG DELIVERY MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 64: GLOBAL DRUG DELIVERY MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 65: GLOBAL DRUG DELIVERY MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 66: GLOBAL DRUG DELIVERY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 67: GLOBAL DRUG DELIVERY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 68: NORTH AMERICA DRUG DELIVERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 69: NORTH AMERICA DRUG DELIVERY MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 70: LEADING PLAYERS OPERATING IN NORTH AMERICA DRUG DELIVERY MARKET

    TABLE 71: EUROPE DRUG DELIVERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 72: EUROPE DRUG DELIVERY MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 73: LEADING PLAYERS OPERATING IN EUROPE DRUG DELIVERY MARKET

    TABLE 74: ASIA-PACIFIC DRUG DELIVERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 75: ASIA-PACIFIC DRUG DELIVERY MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 76: LEADING PLAYERS OPERATING IN ASIA-PACIFIC DRUG DELIVERY MARKET

    TABLE 77: REST OF WORLD DRUG DELIVERY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ BILLION)

    TABLE 78: REST OF WORLD DRUG DELIVERY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ BILLION)

    TABLE 79: LEADING PLAYERS OPERATING IN REST OF WORLD DRUG DELIVERY MARKET

    TABLE 80: LIST OF MERGERS & ACQUISITIONS

    TABLE 81: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 82: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 83: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES                        

    LIST OF FIGURES

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: GLOBAL DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, IN 2021

    FIGURE 6: GLOBAL DRUG DELIVERY MARKET, BY ORAL DRUG DELIVERY, 2022-2030 (IN $ BILLION)

    FIGURE 7: GLOBAL ORAL DRUG DELIVERY MARKET, BY SOLID ORAL DRUGS, 2022-2030 (IN $ BILLION)

    FIGURE 8: GLOBAL SOLID ORAL DRUGS MARKET, BY TABLETS, 2022-2030 (IN $ BILLION)

    FIGURE 9: GLOBAL SOLID ORAL DRUGS MARKET, BY CAPSULES, 2022-2030 (IN $ BILLION)

    FIGURE 10: GLOBAL SOLID ORAL DRUGS MARKET, BY POWDERS, 2022-2030 (IN $ BILLION)

    FIGURE 11: GLOBAL SOLID ORAL DRUGS MARKET, BY PILLS, 2022-2030 (IN $ BILLION)

    FIGURE 12: GLOBAL ORAL DRUG DELIVERY MARKET, BY LIQUID ORAL DRUGS, 2022-2030 (IN $ BILLION)

    FIGURE 13: GLOBAL LIQUID ORAL DRUGS MARKET, BY SOLUTIONS, 2022-2030 (IN $ BILLION)

    FIGURE 14: GLOBAL LIQUID ORAL DRUGS MARKET, BY SYRUPS, 2022-2030 (IN $ BILLION)

    FIGURE 15: GLOBAL ORAL DRUG DELIVERY MARKET, BY SEMI-SOLID ORAL DRUGS, 2022-2030 (IN $ BILLION)

    FIGURE 16: GLOBAL SEMI-SOLID ORAL DRUGS MARKET, BY ORAL EMULSIONS, 2022-2030 (IN $ BILLION)

    FIGURE 17: GLOBAL SEMI-SOLID ORAL DRUGS MARKET, BY GELS, 2022-2030 (IN $ BILLION)

    FIGURE 18: GLOBAL SEMI-SOLID ORAL DRUGS MARKET, BY ELIXIRS, 2022-2030 (IN $ BILLION)

    FIGURE 19: GLOBAL DRUG DELIVERY MARKET, BY INJECTABLE DRUG DELIVERY, 2022-2030 (IN $ BILLION)

    FIGURE 20: GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY FORMULATIONS, 2022-2030 (IN $ BILLION)

    FIGURE 21: GLOBAL FORMULATIONS MARKET, BY CONVENTIONAL DRUG DELIVERY INJECTIONS, 2022-2030 (IN $ BILLION)

    FIGURE 22: GLOBAL FORMULATIONS MARKET, BY LONG ACTING INJECTABLE, 2022-2030 (IN $ BILLION)

    FIGURE 23: GLOBAL FORMULATIONS MARKET, BY NOVEL DRUG DELIVERY FORMULATIONS, 2022-2030 (IN $ BILLION)

    FIGURE 24: GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY DEVICES, 2022-2030 (IN $ BILLION)

    FIGURE 25: GLOBAL DEVICES MARKET, BY CONVENTIONAL INJECTION DEVICES, 2022-2030 (IN $ BILLION)

    FIGURE 26: GLOBAL CONVENTIONAL INJECTION DEVICES MARKET, BY PLASTIC, 2022-2030 (IN $ BILLION)

    FIGURE 27: GLOBAL CONVENTIONAL INJECTION DEVICES MARKET, BY GLASS, 2022-2030 (IN $ BILLION)

    FIGURE 28: GLOBAL CONVENTIONAL INJECTION DEVICES MARKET, BY FILLABLE SYRINGES, 2022-2030 (IN $ BILLION)

    FIGURE 29: GLOBAL CONVENTIONAL INJECTION DEVICES MARKET, BY PREFILLED SYRINGES, 2022-2030 (IN $ BILLION)

    FIGURE 30: GLOBAL CONVENTIONAL INJECTION DEVICES MARKET, BY DISPOSABLE SYRINGES, 2022-2030 (IN $ BILLION)

    FIGURE 31: GLOBAL CONVENTIONAL INJECTION DEVICES MARKET, BY REUSABLE SYRINGES, 2022-2030 (IN $ BILLION)

    FIGURE 32: GLOBAL DEVICES MARKET, BY SELF-INJECTION DEVICES, 2022-2030 (IN $ BILLION)

    FIGURE 33: GLOBAL SELF-INJECTION DEVICES MARKET, BY NEEDLE-FREE INJECTOR, 2022-2030 (IN $ BILLION)

    FIGURE 34: GLOBAL SELF-INJECTION DEVICES MARKET, BY PEN INJECTOR, 2022-2030 (IN $ BILLION)

    FIGURE 35: GLOBAL SELF-INJECTION DEVICES MARKET, BY AUTO-INJECTOR, 2022-2030 (IN $ BILLION)

    FIGURE 36: GLOBAL SELF-INJECTION DEVICES MARKET, BY WEARABLE INJECTOR, 2022-2030 (IN $ BILLION)

    FIGURE 37: GLOBAL DEVICES MARKET, BY OTHER INJECTOR DEVICES, 2022-2030 (IN $ BILLION)

    FIGURE 38: GLOBAL DRUG DELIVERY MARKET, BY PULMONARY DRUG DELIVERY, 2022-2030 (IN $ BILLION)

    FIGURE 39: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY DEVICES, 2022-2030 (IN $ BILLION)

    FIGURE 40: GLOBAL DEVICES MARKET, BY METERED DOSE INHALERS (MDIS), 2022-2030 (IN $ BILLION)

    FIGURE 41: GLOBAL DEVICES MARKET, BY NEBULIZERS, 2022-2030 (IN $ BILLION)

    FIGURE 42: GLOBAL NEBULIZERS MARKET, BY JET NEBULIZERS, 2022-2030 (IN $ BILLION)

    FIGURE 43: GLOBAL NEBULIZERS MARKET, BY ULTRASONIC NEBULIZERS DELIVERY, 2022-2030 (IN $ BILLION)

    FIGURE 44: GLOBAL NEBULIZERS MARKET, BY SOFT MIST NEBULIZERS, 2022-2030 (IN $ BILLION)

    FIGURE 45: GLOBAL DEVICES MARKET, BY DRY POWDER SYSTEM, 2022-2030 (IN $ BILLION)

    FIGURE 46: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY FORMULATIONS, 2022-2030 (IN $ BILLION)

    FIGURE 47: GLOBAL DRUG DELIVERY MARKET, BY TOPICAL DRUG DELIVERY, 2022-2030 (IN $ BILLION)

    FIGURE 48: GLOBAL TOPICAL DRUG DELIVERY MARKET, BY FORMULATION, 2022-2030 (IN $ BILLION)

    FIGURE 49: GLOBAL FORMULATIONS MARKET, BY SEMI-SOLID TOPICAL DRUG DELIVERY, 2022-2030 (IN $ BILLION)

    FIGURE 50: GLOBAL SEMI-SOLID TOPICAL DRUG DELIVERY MARKET, BY CREAMS, 2022-2030 (IN $ BILLION)

    FIGURE 51: GLOBAL SEMI-SOLID TOPICAL DRUG DELIVERY MARKET, BY OINTMENTS, 2022-2030 (IN $ BILLION)

    FIGURE 52: GLOBAL SEMI-SOLID TOPICAL DRUG DELIVERY MARKET, BY LOTIONS, 2022-2030 (IN $ BILLION)

    FIGURE 53: GLOBAL SEMI-SOLID TOPICAL DRUG DELIVERY MARKET, BY GELS, 2022-2030 (IN $ BILLION)

    FIGURE 54: GLOBAL SEMI-SOLID TOPICAL DRUG DELIVERY MARKET, BY PASTES, 2022-2030 (IN $ BILLION)

    FIGURE 55: GLOBAL FORMULATIONS MARKET, BY LIQUID TOPICAL DRUG DELIVERY, 2022-2030 (IN $ BILLION)

    FIGURE 56: GLOBAL LIQUID TOPICAL DRUG DELIVERY MARKET, BY SOLUTIONS, 2022-2030 (IN $ BILLION)

    FIGURE 57: GLOBAL LIQUID TOPICAL DRUG DELIVERY MARKET, BY SUSPENSIONS, 2022-2030 (IN $ BILLION)

    FIGURE 58: GLOBAL FORMULATIONS MARKET, BY SOLID TOPICAL DRUG DELIVERY, 2022-2030 (IN $ BILLION)

    FIGURE 59: GLOBAL SOLID TOPICAL DRUG DELIVERY MARKET, BY POWDERS, 2022-2030 (IN $ BILLION)

    FIGURE 60: GLOBAL SOLID TOPICAL DRUG DELIVERY MARKET, BY SUPPOSITORIES, 2022-2030 (IN $ BILLION)

    FIGURE 61: GLOBAL TOPICAL DRUG DELIVERY MARKET, BY DEVICES, 2022-2030 (IN $ BILLION)

    FIGURE 62: GLOBAL DEVICES MARKET, BY TRANSDERMAL PATCHES, 2022-2030 (IN $ BILLION)

    FIGURE 63: GLOBAL DEVICES MARKET, BY TRANSDERMAL GELS, 2022-2030 (IN $ BILLION)

    FIGURE 64: GLOBAL DRUG DELIVERY MARKET, BY NASAL DRUG DELIVERY, 2022-2030 (IN $ BILLION)

    FIGURE 65: GLOBAL NASAL DRUG DELIVERY MARKET, BY NASAL SPRAYS, 2022-2030 (IN $ BILLION)

    FIGURE 66: GLOBAL NASAL DRUG DELIVERY MARKET, BY NASAL DROPS, 2022-2030 (IN $ BILLION)

    FIGURE 67: GLOBAL NASAL DRUG DELIVERY MARKET, BY NASAL GELS, 2022-2030 (IN $ BILLION)

    FIGURE 68: GLOBAL NASAL DRUG DELIVERY MARKET, BY NASAL POWDERS, 2022-2030 (IN $ BILLION)

    FIGURE 69: GLOBAL DRUG DELIVERY MARKET, BY OCULAR DRUG DELIVERY, 2022-2030 (IN $ BILLION)

    FIGURE 70: GLOBAL OCULAR DRUG DELIVERY MARKET, BY FORMULATIONS, 2022-2030 (IN $ BILLION)

    FIGURE 71: GLOBAL FORMULATION MARKET, BY LIQUID FORMULATION, 2022-2030 (IN $ BILLION)

    FIGURE 72: GLOBAL LIQUID FORMULATION MARKET, BY EYE DROPS, 2022-2030 (IN $ BILLION)

    FIGURE 73: GLOBAL LIQUID FORMULATION MARKET, BY LIQUID SPRAYS, 2022-2030 (IN $ BILLION)

    FIGURE 74: GLOBAL FORMULATION MARKET, BY SEMI-SOLID FORMULATION, 2022-2030 (IN $ BILLION)

    FIGURE 75: GLOBAL SEMI-SOLID FORMULATION MARKET, BY EYE OINTMENTS, 2022-2030 (IN $ BILLION)

    FIGURE 76: GLOBAL SEMI-SOLID FORMULATION MARKET, BY GELS, 2022-2030 (IN $ BILLION)

    FIGURE 77: GLOBAL OCULAR DRUG DELIVERY MARKET, BY OCULAR DEVICES, 2022-2030 (IN $ BILLION)

    FIGURE 78: GLOBAL OCULAR DEVICES MARKET, BY DRUG-COATED CONTACT LENSES, 2022-2030 (IN $ BILLION)

    FIGURE 79: GLOBAL OCULAR DEVICES MARKET, BY OCULAR INSERT, 2022-2030 (IN $ BILLION)

    FIGURE 80: GLOBAL DRUG DELIVERY MARKET, BY TRANSMUCOSAL DRUG DELIVERY, 2022-2030 (IN $ BILLION)

    FIGURE 81: GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET, BY ORAL TRANSMUCOSAL DRUG DELIVERY, 2022-2030 (IN $ BILLION)

    FIGURE 82: GLOBAL ORAL TRANSMUCOSAL DRUG DELIVERY MARKET, BY BUCCAL DRUG DELIVERY, 2022-2030 (IN $ BILLION)

    FIGURE 83: GLOBAL ORAL TRANSMUCOSAL DRUG DELIVERY MARKET, BY SUBLINGUAL DRUG DELIVERY, 2022-2030 (IN $ BILLION)

    FIGURE 84: GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET, BY OTHER TRANSMUCOSAL DRUG DELIVERY, 2022-2030 (IN $ BILLION)

    FIGURE 85: GLOBAL OTHER TRANSMUCOSAL DRUG DELIVERY MARKET, BY RECTAL TRANSMUCOSAL DRUG DELIVERY, 2022-2030 (IN $ BILLION)

    FIGURE 86: GLOBAL OTHER TRANSMUCOSAL DRUG DELIVERY MARKET, BY VAGINAL TRANSMUCOSAL DRUG DELIVERY, 2022-2030 (IN $ BILLION)

    FIGURE 87: GLOBAL DRUG DELIVERY MARKET, BY IMPLANTABLE DRUG DELIVERY, 2022-2030 (IN $ BILLION)

    FIGURE 88: GLOBAL IMPLANTABLE DRUG DELIVERY MARKET, BY ACTIVE IMPLANTABLE DRUG DELIVERY, 2022-2030 (IN $ BILLION)

    FIGURE 89: GLOBAL IMPLANTABLE DRUG DELIVERY MARKET, BY PASSIVE IMPLANTABLE DRUG DELIVERY, 2022-2030 (IN $ BILLION)

    FIGURE 90: GLOBAL DRUG DELIVERY MARKET, BY END-USER, IN 2021

    FIGURE 91: GLOBAL DRUG DELIVERY MARKET, BY HOSPITALS, 2022-2030 (IN $ BILLION)

    FIGURE 92: GLOBAL DRUG DELIVERY MARKET, BY AMBULATORY SURGICAL CENTERS, 2022-2030 (IN $ BILLION)

    FIGURE 93: GLOBAL DRUG DELIVERY MARKET, BY HOME CARE SETTINGS, 2022-2030 (IN $ BILLION)

    FIGURE 94: GLOBAL DRUG DELIVERY MARKET, BY OTHER END-USERS, 2022-2030 (IN $ BILLION)

    FIGURE 95: NORTH AMERICA DRUG DELIVERY MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

    FIGURE 96: UNITED STATES DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)

    FIGURE 97: CANADA DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)

    FIGURE 98: EUROPE DRUG DELIVERY MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

    FIGURE 99: GERMANY DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)

    FIGURE 100: FRANCE DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)

    FIGURE 101: UNITED KINGDOM DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)

    FIGURE 102: ITALY DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)

    FIGURE 103: SPAIN DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)

    FIGURE 104: RUSSIA DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)

    FIGURE 105: POLAND DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)

    FIGURE 106: BELGIUM DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)

    FIGURE 107: REST OF EUROPE DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)

    FIGURE 108: ASIA-PACIFIC DRUG DELIVERY MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

    FIGURE 109: CHINA DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)

    FIGURE 110: JAPAN DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)

    FIGURE 111: INDIA DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)

    FIGURE 112: AUSTRALIA & NEW ZEALAND DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)

    FIGURE 113: SOUTH KOREA DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)

    FIGURE 114: INDONESIA DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)

    FIGURE 115: THAILAND DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)

    FIGURE 116: VIETNAM DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)

    FIGURE 117: REST OF ASIA-PACIFIC DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)

    FIGURE 118: REST OF WORLD DRUG DELIVERY MARKET, REGIONAL OUTLOOK, 2021 & 2030 (IN %)

    FIGURE 119: LATIN AMERICA DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)

    FIGURE 120: MIDDLE EAST & AFRICA DRUG DELIVERY MARKET, 2022-2030 (IN $ BILLION)  

    1. MARKET BY ROUTE OF ADMINISTRATION
      • ORAL DRUG DELIVERY
        • SOLID ORAL DRUGS
          • TABLETS
          • CAPSULES
          • POWDERS
          • PILLS
        • LIQUID ORAL DRUGS
          • SOLUTIONS
          • SYRUPS
        • SEMI-SOLID ORAL DRUGS
          • ORAL EMULSIONS
          • GELS
          • ELIXIRS
      • INJECTABLE DRUG DELIVERY
        • FORMULATIONS
          • CONVENTIONAL DRUG DELIVERY INJECTIONS
          • LONG ACTING INJECTABLE
          • NOVEL DRUG DELIVERY FORMULATIONS
        • DEVICES
          • CONVENTIONAL INJECTION DEVICES
            • CONVENTIONAL INJECTION DEVICES BY MATERIAL
              • PLASTIC
              • GLASS
            • CONVENTIONAL INJECTION DEVICES BY PRODUCT
              • FILLABLE SYRINGES
              • PREFILLED SYRINGES
            • CONVENTIONAL INJECTION DEVICES BY USABILITY
              • DISPOSABLE SYRINGES
              • REUSABLE SYRINGES
            • SELF-INJECTION DEVICES
              • NEEDLE-FREE INJECTORS
              • PEN INJECTORS
              • AUTO-INJECTOR
              • WEARABLE INJECTORS
            • OTHER INJECTOR DEVICES
      • PULMONARY DRUG DELIVERY
        • DEVICES
          • METERED DOSE INHALERS (MDIS)
          • NEBULIZERS
            • JET NEBULIZERS
            • ULTRASONIC NEBULIZERS DELIVERY
            • SOFT MIST NEBULIZERS
          • DRY POWDER SYSTEM
        • FORMULATIONS
      • TOPICAL DRUG DELIVERY
        • FORMULATIONS
          • SEMI-SOLID TOPICAL DRUG DELIVERY
            • CREAMS
            • OINTMENTS
            • LOTIONS
            • GELS
            • PASTES
          • LIQUID TOPICAL DRUG DELIVERY
            • SOLUTIONS
            • SUSPENSIONS
          • SOLID TOPICAL DRUG DELIVERY
            • POWDERS
            • SUPPOSITORIES
          • DEVICES
            • TRANSDERMAL PATCHES
            • TRANSDERMAL GELS
      • NASAL DRUG DELIVERY
        • NASAL SPRAYS
        • NASAL DROPS
        • NASAL GELS
        • NASAL POWDERS
      • OCULAR DRUG DELIVERY
        • FORMULATIONS
          • LIQUID FORMULATION
            • EYE DROPS
            • LIQUID SPRAYS
          • SEMISOLID FORMULATION
            • EYE OINTMENTS
            • GELS
          • OCULAR DEVICES
            • DRUG-COATED CONTACT LENSES
            • OCULAR INSERT
      • TRANSMUCOSAL DRUG DELIVERY
        • ORAL TRANSMUCOSAL DRUG DELIVERY
          • BUCCAL DRUG DELIVERY
          • SUBLINGUAL DRUG DELIVERY
        • OTHER TRANSMUCOSAL DRUG DELIVERY
          • RECTAL TRANSMUCOSAL DRUG DELIVERY
          • VAGINAL TRANSMUCOSAL DRUG DELIVERY
      • IMPLANTABLE DRUG DELIVERY
        • ACTIVE IMPLANTABLE DRUG DELIVERY
        • PASSIVE IMPLANTABLE DRUG DELIVERY
    1. MARKET BY END-USER
      • HOSPITALS
      • AMBULATORY SURGICAL CENTERS
      • HOME CARE SETTINGS
      • OTHER END-USERS
    2. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • GERMANY
          • FRANCE
          • UNITED KINGDOM
          • ITALY
          • SPAIN
          • RUSSIA
          • POLAND
          • BELGIUM
          • REST OF EUROPE
      • ASIA-PACIFIC
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • CHINA
          • JAPAN
          • INDIA
          • AUSTRALIA & NEW ZEALAND
          • SOUTH KOREA
          • INDONESIA
          • THAILAND
          • VIETNAM
          • REST OF ASIA-PACIFIC
      • REST OF WORLD
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • REGIONAL ANALYSIS
          • LATIN AMERICA
          • MIDDLE EAST & AFRICA

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type